Drug
Cetrorelix clinical trials
Also written Cetrotide.
- studies test it
- 40
- open now
- 2
- in phase 3
- 6
- first study started
- 2003
Keep track of what changes. Save the cetrorelix studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Brand
Other names
Combined with it in one product
Studies by the year they started
38 studies that test it; most in 2008 (4)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 1 |
| 2012 | 2 |
| 2013 | 2 |
| 2014 | 2 |
| 2015 | 3 |
| 2017 | 3 |
| 2018 | 3 |
| 2019 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2024 | 2 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 2
- Phase 1
- 1
- Phase 2
- 5
- Phase 3
- 6
- Phase 4
- 16
- No phase
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 6 · Other 34
Damascus University (4) · University of Colorado, Denver (3) · Cairo University (3) · AEterna Zentaris (2) · Mỹ Đức Hospital (1) · Assistance Publique - Hôpitaux de Paris (1) · El Shatby University Hospital for Obstetrics and Gynecology (1) · ClinAmygate (1)
Often tested with
Tested in the same studies.
Dydrogesterone (3) · Chorionic Gonadotropin (3) · Follitropin alfa (2) · Estradiol (2) · Letrozole (2) · Degarelix (1) · Triptorelin (1) · Gonadorelin diacetate tetrahydrate (1)
Studies
Open first, then newest update. How each study uses cetrorelix is read from its arms, and is right about nine times in ten.
Testing it · 40
- Effectiveness of Generic Versus Reference Cetrorelix Acetate for Ovarian Stimulation Using a Gonadotropin-releasing Hormone（GnRH）Antagonist Protocol in Women Undergoing IVFRecruitingNot applicableNorthwest Women's and Children's Hospital, Xi'an, ShaanxiNCT06023602Written as Generic cetrorelix acetate
- Sex Differences in Myocardial Steatosis Induced Left Ventricular DysfunctionRecruitingPhase 4The University of Texas at ArlingtonNCT04671966Written as Cetrotide
- NATural Ovarian StimulationCompletedPhase 4Assistance Publique - Hôpitaux de ParisNCT02892942Written as Cetrotide®
- PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)Active, not recruitingNot applicableMỹ Đức HospitalNCT06378268Written as Cetrorelix 0.25 mg
- Dysregulation of FSH in Obesity: Functional and Statistical AnalysisCompletedNot applicableUniversity of Colorado, DenverNCT02478775Written as Cetrorelix
- Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology During IVF/ICSICompletedPhase 4Damascus UniversityNCT04724486Written as Cetrorelix
- Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes.CompletedPhase 4Damascus UniversityNCT04724343Written as Cetrorelix
- Effect of GnRH Agonist vs GnRH Antagonist on Oocyte Morphology in Polycystic Ovary Syndrome Patients During IVF/ICSICompletedPhase 4Damascus UniversityNCT04727684Written as Cetrorelix
- Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients.CompletedPhase 4Damascus UniversityNCT04727671Written as Cetrorelix
- Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor RespondersCompletedPhase 3El Shatby University Hospital for Obstetrics and GynecologyNCT04537078Written as Cetrotide Injectable Product
- Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI CyclesStatus unknownNot applicableMansoura UniversityNCT05112692Written as cetrorelix 0.25mg
- The Aromatase Inhibitor and Gnrh Antagonist Versus Methotrexate for Management of Undisturbed Ectopic PregnancyStatus unknownNot applicableAssiut UniversityNCT04308343Written as cetrotide
- Sex Hormones and Atherosclerosis Prevention in Perimenopausal WomenCompletedEarly Phase 1University of Colorado, DenverNCT02042196Written as Cetrotide
- Efficacy of Growth Hormone Supplementation With Gonadotrophins in IVF/ICSI for Poor RespondersCompletedPhase 4ClinAmygateNCT03759301Written as Growth Hormones Somatropin Recombinant
- Frozen Embryo Transfer With GnRH-antagonist TrialStatus unknownPhase 4University of OxfordNCT03763786Written as Cetrorelix Acetate
- Cetrorelix (CET) Pamoate Regimens in Patients With Symptomatic Benign Prostatic Hypertrophy (BPH)TerminatedPhase 3AEterna ZentarisNCT00449150Written as Cetrorelix 78 mg + 78 mg
- Cetrorelix and Ganirelix Flexible Protocol for (IVF)Status unknownPhase 4Università degli Studi 'G. d'Annunzio' Chieti e PescaraNCT03477929Written as Cetrorelix Acetate
- Long Protocol and Freeze All Embryos vs Antagonist Protocol With Fresh Embryo Transfer in PCOS Patients Undergoing ICSICompletedPhase 4Cairo UniversityNCT03118830Written as cetrorelix
- Comparing Ovarian Stimulation for Assisted Reproduction With Two Different Forms of Pituitary SuppressionCompletedNot applicableUniversity Hospital, Basel, SwitzerlandNCT01565265Written as Pergoveris in GnRH antagonist protocol
- Outcome of Cetrotide Therapy for Management of Women at High-risk of Ovarian Hyperstimulation SyndromeStatus unknownPhase 2/3Benha UniversityNCT02823080Written as Cetrorelix
See all 40 studies that test cetrorelix →
Given in every arm · 7 — cetrorelix is usual care beside what is tested
- A Study to Compare the Efficacy and Safety of Follitropin Alfa/Lutropin Alfa Versus hMG in Japanese Participants With LH and FSH Deficiency Undergoing ART (HINATA)RecruitingPhase 3Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyNCT07340827Written as Cetrorelix acetate
- Testosterone and Neurovascular Control in HumansStatus unknownNot applicableWestern University, CanadaNCT04819204Written as Cetrorelix Acetate
- Estrogen, Diabetes, and Endothelial FunctionCompletedNot applicableUniversity of Colorado, DenverNCT04418908Written as Cetrorelix acetate, 0.25 mg/day
- Comparison Between Two Different Protocols in Polycystic Ovary Symdrome Women Undergoing Intra-cytoplasmic InjectionStatus unknownPhase 4Assiut UniversityNCT04094467Written as Cetrorelix
- Patients' Preference for Subcutaneous or Vaginal Progesterone as Luteal Support in IVF/ICSI CyclesTerminatedPhase 4Andros Day Surgery ClinicNCT03181685Written as Cetrorelix Acetate
- Lutropin Alfa in Women at Risk of Poor ResponseCompletedPhase 2Merck KGaA, Darmstadt, GermanyNCT01112358Written as Analogous GnRH antagonist
- Progesterone Serum Levels in Subfertile Female Patients Undergoing in Vitro Fertilisation (IVF)CompletedPhase 4Ferring PharmaceuticalsNCT01225835Written as Cetrorelix
As the comparator · 12 — what is tested is compared with cetrorelix
- Oral GnRH Antagonist (Linzagolix) Versus Injectable GnRH Antagonist in Controlled Ovarian Stimulation for In Vitro Fertilization: A Randomized Controlled Non-Inferiority Trial With a Concurrent Comparator Cohort Undergoing Progestin-Primed Ovarian Stimulation (PPOS)Not yet recruitingNot applicableCentro A.M.B.R.A. (Associazione Medici e Biologi per la Riproduzione Assistita)NCT07732348Written as Ganirelix ; Cetrorelix
- Drospirenone-Primed Ovarian Stimulation Versus GnRH Antagonist Protocol in Poor Ovarian Responders Undergoing Freeze-All IVF/ICSINot yet recruitingPhase 1/2Ahmed SaadNCT07736261Written as Cetrorelix 0.25 mg
- Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection OutcomesRecruitingPhase 3Beni-Suef UniversityNCT05972902Written as Cetrorelix acetate
- Efficacy and Safety of BG2109 During Controlled Ovarian Hyperstimulation in Female Subjects Undergoing ART ProceduresNot yet recruitingPhase 2Bio Genuine (Shanghai) Biotech Co., Ltd.NCT05738382Written as Cetrorelix
- Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSICompletedPhase 2/3Beni-Suef UniversityNCT05951400Written as Cetrorelix
- Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVFTerminatedNot applicableShangHai Ji Ai Genetics & IVF InstituteNCT03680053Written as Cetrorelix
- PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical TrialCompletedPhase 3Kasr El Aini HospitalNCT06868576Written as Cetrorelix (Cetrotide)
- Can Drospirenone be Used to Prevent LH Surge in Controlled Ovarian Stimulation in PCOS?!CompletedPhase 1/2Ahmed SaadNCT06608186Written as Cetrorelix drug
- Follitropin Delta in Long GnRH Agonist and GnRH Antagonist Protocols (BEYOND)CompletedPhase 3Ferring PharmaceuticalsNCT03809429Written as FE 999049 + GnRH antagonist (CETROTIDE)
- Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSIStatus unknownNot applicableZagazig UniversityNCT05751681Written as Cetrotide
- Use of Degarelix in Controlled Ovarian Hyperstimulation (COH) Protocol for Women With PoliCystic Ovarian Syndrome (PCOS)CompletedPhase 3Centre for Endocrinology and Reproductive Medicine, ItalyNCT01709942Written as cetrorelix 0.25mg
- Ovarian Stimulation Using Recombinant Follicle-stimulating Hormone (FSH) and Gonadotrophin Releasing Hormone (GnRH) Agonist in Alternate DaysCompletedNot applicableFertility - Assisted Fertilization CenterNCT01468441Written as Cetrorelix
Codes
What other systems call cetrorelix · ClinicalTrials.gg INT003487
- MeSH (NLM) C062876cetrorelixConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) OON1HFZ4BACETRORELIXConfirmed FDA, NLM, Wikidata
- RxNorm 68147Confirmed FDA, Wikidata
- Wikidata Q5065704cetrorelixConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C2481CetrorelixOne source FDA
- DrugBank DB00050One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C062876 | cetrorelix | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | OON1HFZ4BA | CETRORELIX | Confirmed FDA, NLM, Wikidata |
| RxNorm | 68147 | — | Confirmed FDA, Wikidata |
| Wikidata | Q5065704 | cetrorelix | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C2481 | Cetrorelix | One source FDA |
| DrugBank | DB00050 | — | One source Wikidata |
Also registered as cetrorelix acetate (UNII W9Y8L7GP4C · RxNorm 259338) and dicetrorelix pamoate (UNII DY3PDH8A8N).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.